Home
│
Site Map
│
Contact Us
│
Search
│
繁體中文
│
English
About Medigen
Corporate Profile
Corporate Vision
Corporate Objective
Management
Business Activities
New Drug Development
Nucleic Acid Test
Media Room
Investor Relations
Career
~Innovations for a Better Life~
‧2008-10-27
Medigen Enters Into a Letter of Intent With Pacgen Biotech in Canada
‧2008-10-03
Medigen Biotech Received Top Innovation Award by the Ministry of Economic Affairs (MOEA), Taiwan
‧2008-03-17
Oncolys BioPharma Ties Up with Medigen Biotech. For Telomelysin
‧2008-03-05
Oncolys BioPharma and Medigen Biotechnology Enter Strategic Alliance and Licensing Agreement
‧2007-11-28
[Announcment] MBC Collaborates with Academia Sinica for Liver Cancer Development
‧2007-10-17
MBC Co-ops with NTU for New Drug Development
‧2007-09-03
Tetralogy of Complementary Double-Core Business Model
‧2007-08-06
MBC Enters Blood Screening Market in China
‧2007-07-09
Taiwanese Bid for Anti-Cancer Drug
‧2007-07-02
Big Pharmas Favor BioMed-Industry in Taiwan
‧2007-06-16
New Drug PI-88 Decreases Liver Cancer Recurrence to 34%
‧2007-06-15
Liver Cancer Treatment Breakthrough by PI-88 Phase II Trial
‧2007-04-24
New Drug PI-88 Prevents Liver Cancer Recurrence
‧2007-01-17
MBC to Profit from PI-88 Ahead of Time